Analysts’ Perspective: Charter Communications (CHTR), Ralph Lauren (RL), Esperion Therapeutics (ESPR)

Charter Communications Inc. (NASDAQ:CHTR) shares were upgraded by analysts at Telsey Advisory Group from Market Perform to Outperform rating while increasing their price target from $340 to $450.

Charter Communications, Inc. provides broadband communications services.


Brokerage Firm Atlantic Equities upgraded Ralph Lauren Corp. (NYSE:RL) shares from Underweight to Neutral rating with a price target of $93.

Ralph Lauren Corp. engages in the design, marketing and distribution of premium lifestyle products.


Investment Analysts at Jefferies upgraded Esperion Therapeutics Inc. (NASDAQ:ESPR) shares from Hold to Buy rating.

Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at